lomerizine has been researched along with Encephalopathy, Toxic in 2 studies
lomerizine: used to treat migraines
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effects of a new Ca2+ channel blocker, lomerizine, on the intraocular hypertension-induced ischemia/reperfusion injury in rat retina and on the glutamate-induced neurotoxicity in rat cultured retinal neurons, and compared its effects with those of a Ca2+ channel blocker (flunarizine) and an N-methyl-D-aspartate receptor antagonist (MK-801)." | 3.70 | Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. ( Akaike, A; Hara, H; Honda, Y; Kashii, S; Shimazawa, M; Toriu, N; Yasuyoshi, H; Zhang, S, 2000) |
| "Migraine is one of the risk factor for ischemic stroke." | 1.37 | Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity. ( Iizuka, R; Ishii, M; Kiuchi, Y; Mori, Y; Shimizu, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, M | 1 |
| Iizuka, R | 1 |
| Kiuchi, Y | 1 |
| Mori, Y | 1 |
| Shimizu, S | 1 |
| Toriu, N | 1 |
| Akaike, A | 1 |
| Yasuyoshi, H | 1 |
| Zhang, S | 1 |
| Kashii, S | 1 |
| Honda, Y | 1 |
| Shimazawa, M | 1 |
| Hara, H | 1 |
2 other studies available for lomerizine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.
Topics: Animals; Benzamides; Calcium; Calcium Channel Blockers; Cell Death; Cells, Cultured; HEK293 Cells; H | 2011 |
Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina.
Topics: Animals; Calcium Channel Blockers; Cells, Cultured; Dizocilpine Maleate; Dose-Response Relationship, | 2000 |